|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 September 2022 |
|
Main ID: |
NCT02669498 |
|
Date of registration:
|
25/01/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Consequences of Changing Current Standards: Endocrine Status After Routine Fallopian Tube Removal
|
|
Scientific title:
|
Consequences of Changing Current Standards: Endocrine Status After Routine Fallopian Tube Removal |
|
Date of first enrolment:
|
November 2013 |
|
Target sample size:
|
128 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02669498 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Contacts
|
|
Name:
|
Michael D Mueller, Prof. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Women's Hospital Bern, Switzerland |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- benign indication for hysterectomy
- informed consent
Exclusion Criteria:
- Menopause
- Pregnancy
- Previous pelvic surgery (hysterectomy, salpingectomy, tubal ligation,...)
- malignancy
- hormone replacement therapy
Age minimum:
N/A
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Routine Fallopian Tube Removal
|
|
Pelvic Surgery
|
|
Intervention(s)
|
|
Procedure: Routine fallopian tube removal
|
|
Primary Outcome(s)
|
|
Longitudinal changes of FSH pre- and post-operatively
[Time Frame: 6 weeks]
|
|
Secondary Outcome(s)
|
|
Longitudinal changes of LH
[Time Frame: 1 year]
|
|
Longitudinal changes of E2
[Time Frame: 1 year]
|
|
Longitudinal changes of LH
[Time Frame: 6 weeks]
|
|
Longitudinal changes of E2
[Time Frame: 6 weeks]
|
|
Longitudinal changes of AMH
[Time Frame: 1 year]
|
|
Longitudinal changes of AMH
[Time Frame: 6 weeks]
|
|
Longitudinal changes of FSH
[Time Frame: 1 year]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|